The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise ...

A kidney cancer cell nucleus is studded with aberrant nuclear speckles (orange). Normal healthy cells tend to have the speckles clustered toward the middle. Image credit: Kate Alexander (Cold Spring ...

India boasts about ten pharmaceutical hubs, investing heavily in drug production, not just generics. The country has committed over €75 million to research and training institutes, with the ...

The publication reviews the results of 204 patients with 12 tumor types enrolled and treated on the eNRGy study, concluding “Zenocutuzumab demonstrated durable efficacy in patients with advanced NRG1+ ...

The University of Guelph is helping to lead a national effort to reshape Canada’s agri-food sector with $16.3 million in new funding ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker for disease progression. This approach has ...

The company will open its first commercial lab in Miami. First Ascent Biomedical ... The company reports it uses functional precision medicine to create custom treatment plans for cancer patients.

Xavier University Montessori Lab School families say they are "devastated ... expands partnership with Xavier for new College of Medicine TriHealth expands partnership with Xavier for new College ...

U.S. Sen. Rand Paul, the new chairman of the Senate’s Homeland Security and Governmental Affairs Committee, said Thursday a ...

The problem for the lab-leak position is that the U.S. has never had access to the Wuhan lab and has thus been unable to ...